Non-Physiologic Factors Sway Growth Hormone Decisions

Doctors' initiation decisions conform to guidelines; continuation decisions driven by other factors
By Beth Gilbert
HealthDay Reporter

TUESDAY, Aug. 31 (HealthDay News) -- Physicians' decisions to initiate growth hormone (GH) therapy in children with idiopathic short stature are mostly consistent with established guidelines, but their recommendations regarding GH continuation are more strongly influenced by contextual and attitudinal factors than by growth response to therapy, according to research published online Aug. 30 in Pediatrics.

J.B. Silvers, Ph.D., of Case Western Reserve University in Cleveland, and colleagues used a national census study of 727 pediatric endocrinologists to assess how physicians decide to initiate, intensify, or terminate GH treatment in patients with idiopathic short stature.

The investigators found that, in previously untreated children, recommendations to start GH treatment were in line with guidelines and affected by family preferences and physician attitudes. Among children treated with GH, the recommendation to continue GH treatment was dependent on growth response, but there were differences regarding course of action. In children with identical growth responses to GH treatment, independent, non-physiologic, and contextual factors drove physician decisions. The researchers determined that continuation decisions were influenced more by contextual and attitudinal factors than by growth response to therapy.

"With a potential market of 500,000 U.S. children and costs exceeding $10 billion per year, changes in GH use may depend on potentially modifiable physician attitudes and family preferences as much as physiologic evidence," the authors write.

Full Text

Copyright © 2010 HealthDay. All rights reserved.

Powered by

jQuery UI Accordion - Default functionality

For life-long learning and continuing professional development, come to Lippincott's NursingCenter.

Nursing Jobs Plus
Featured Jobs
Recommended CE Articles

Debunking Three Rape Myths
Journal of Forensic Nursing, October/December 2014
Expires: 12/31/2016 CE:2.5 $24.95

Drug updates and approvals: 2014 in review
The Nurse Practitioner, 13December 2014
Expires: 12/31/2016 CE:3 $27.95

Can Food Processing Enhance Cancer Protection?
Nutrition Today, September/October 2014
Expires: 10/31/2016 CE:2 $21.95

More CE Articles

Subscribe to Recommended CE

Recommended Nursing Articles Evidence Based Practice Skin Care Network NursingCenter Quick Links What’s Trending Events